| Value | ₹17.77 Cr |
|---|
NSE filing, NSE: TRENT. Summary written from the filing by ALFA Finder's alert engine.
Trent Ltd: key numbers
- Share price
- ₹2,861.70
- Market cap
- ₹1,52,595 Cr
- Revenue (annual)
- ₹20,074 Cr
- Net profit (annual)
- ₹1,720 Cr
- P/E (TTM)
- 84.3×Sector 61.5×
- Promoter holding
- 37.01%+0.00% QoQ
- FII holding
- 15.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Trent Ltd
All →Trent Management Change
Noel Tata retires as Chairman effective 11 November 2026; Bahram Vakil succeeds him. Rajiv Dube and Kalpana Merchant join as directors, pending shareholder approval.
Trent Results Update
Trent's Q2FY27 consolidated revenue rose 22% to Rs 5,873 crore, with operating EBITDA up 37%. Standalone revenue grew 23% in the quarter.
Trent Investor Presentation: Key Takeaways
Trent Q2 FY27 standalone revenue ₹5,788 Cr (+23%), Op EBITDA ₹791 Cr (+37%), PAT ₹490 Cr (+9%). Store expansion and Star growth drive results; fashion LFL mid-single digit.
Trent Q2 FY27 Results: Net Profit ₹468.1 Cr, Up 25.4% YoY
Trent Ltd reported revenue from operations of ₹5,873 Cr (+21.9% YoY) and net profit of ₹468.1 Cr (+25.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹468.1 Cr · +25.4% YoY
Trent Merger & Restructuring Worth ₹171.9 Cr
Trent agreed on 22 October 2026 to sell a unit or subsidiary to TreBits Investment Trust, an unrelated buyer. Completion is expected by 31 December 2026.
- Value
- ₹171.9 Cr
Trent Merger & Restructuring
Trent's subsidiary Nahar signed a binding term sheet to divest 100% of Netria Property Holdings to TreBits REIT. Consideration is Rs 11.25 per share plus about Rs 171.91 crore of loan repayment, subject to conditions.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.